Predicted to be a structural constituent of skin epidermis. Predicted to be involved in several processes, including intermediate filament organization; keratinization; and wound healing. Predicted to be active in keratin filament. Human ortholog(s) of this gene implicated in focal or diffuse nonepidermolytic palmoplantar keratoderma and pachyonychia congenita. Orthologous to human KRT6B (keratin 6B) and KRT6C (keratin 6C); INTERACTS WITH lead diacetate; 1-chloro-2,4-dinitrobenzene (ortholog); 17beta-estradiol (ortholog).
CK 6A; CK-6A; cytokeratin-6A; K6a keratin; keratin K6; keratin, type II cytoskeletal 5; keratin, type II cytoskeletal 5-like; keratin, type II cytoskeletal 6A; keratin-6A; Krt6a; LOC102551453; LOC683313; similar to keratin complex 2, basic, gene 6a; type-II keratin Kb6
[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT6C mRNA
[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT6C mRNA
[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of KRT6C mRNA